Report - HIGHLIGHTS OF PRESCRIBING INFORMATION ......2020/05/28  · 5.2 Myelosuppression 5.3 Secondary Myelodysplastic Syndrome and Leukemia 5.4 Renal Toxicity 5.5 Hepatotoxicity 5.6 Neuroendocrine

Please pass captcha verification before submit form